7 studies found for:    Mapatumumab
Show Display Options
Rank Status Study
1 Recruiting Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer
Condition: Advanced Cervical Cancer
Interventions: Drug: mapatumumab;   Drug: cisplatin;   Radiation: radiotherapy
2 Completed Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Biological: Mapatumumab;   Drug: Bortezomib
3 Completed A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Biological: Mapatumumab;   Drug: Paclitaxel;   Drug: Carboplatin
4 Active, not recruiting Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: sorafenib;   Biological: mapatumumab
5 Completed A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Biological: mapatumumab;   Drug: sorafenib
6 Completed Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: TRAIL-R1 mAb (TRM-1;HGS-ETR1)
7 Completed Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: TRAIL-R1 mAb (TRM-1; HGS-ETR1)

Indicates status has not been verified in more than two years